- Home
- Companies
- canada alberta
- antigen specificity
Refine by
Antigen Specificity Service Provider Serving Alberta
4 companies found
Service providerbased inAtlanta, GEORGIA (US) (USA)
Metaclipse Therapeutics Corporation is developing novel personalized vaccine immunotherapies for cancer. MembrexTM, a proprietary platform approach tailored to each patient and their specific tumor, consists of ‘membrane vesicles’ prepared from a ...
Metaclipse Therapeutics Corporation is developing novel personalized vaccine immunotherapies for cancer. MembrexTM, a proprietary platform approach tailored to each patient and their specific tumor, consists of ‘membrane ...
Service providerbased inWijchen, NETHERLANDS
Future Diagnostics is the obvious choice for in vitro diagnostic (IVD) assay development – for start-ups, mid-sized biotech companies and multinationals in the global IVD medical device market. With 20+ years of expert experience and 150 IVD ...
Besides our services for the development of complete IVD immunoassays, we also offer a conjugation service. This service is normally part of an IVD product development but can also be offered as a separate project. ...
Service providerbased in, MASSACHUSETTS (USA)
MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The ...
T cells play a vital role in destroying pathogens and monitoring pathological cells. They are able to distinguish between self-antigens and non-self-antigens by surface T cell receptors (TCRs). Most human T cells express the classical TCRs, which ...
Service providerbased inWroclaw, POLAND
Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based ...
Triple-negative breast cancer (TNBC) is a highly proliferative, rapidly growing, and aggressive form of cancer. TNBC can be further categorized into three types: Type 1 (also known as the “cold” type) is characterized by a tumor with low ...